Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

U.S. Pharma Industry Analysis

UpdatedDec 21, 2024
DataAggregated Company Financials
Companies295
  • 7D-1.6%
  • 3M-12.2%
  • 1Y7.8%
  • YTD4.1%

Over the last 7 days, the Pharma industry has dropped 2.0%, driven by a pullback from Eli Lilly of 2.7%. In contrast, Teva Pharmaceutical Industries has gained 34%. Over the past 12 months, the industry was up 7.6%. Looking forward, earnings are forecast to grow by 24% annually.

Industry Valuation and Performance

Has the U.S. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 21 Dec 2024US$1.8tUS$369.4bUS$31.1b16.7x56.8x4.8x
Mon, 18 Nov 2024US$1.8tUS$373.9bUS$30.5b19.1x58.4x4.8x
Wed, 16 Oct 2024US$2.0tUS$365.3bUS$23.7b18.5x85.7x5.6x
Fri, 13 Sep 2024US$2.0tUS$364.2bUS$25.5b18.5x79.5x5.6x
Sun, 11 Aug 2024US$2.0tUS$362.1bUS$22.0b17.1x89.6x5.4x
Tue, 09 Jul 2024US$2.0tUS$357.6bUS$13.8b15.4x141.8x5.5x
Thu, 06 Jun 2024US$1.9tUS$358.3bUS$14.1b15.6x135.7x5.3x
Sat, 04 May 2024US$1.8tUS$358.0bUS$13.8b21.4x131x5.1x
Mon, 01 Apr 2024US$1.9tUS$355.2bUS$22.7b22.7x84.2x5.4x
Wed, 28 Feb 2024US$1.9tUS$355.2bUS$23.8b24.4x80.1x5.4x
Fri, 26 Jan 2024US$1.8tUS$375.2bUS$33.9b26x51.8x4.7x
Sun, 24 Dec 2023US$1.7tUS$375.2bUS$33.9b26.7x49.3x4.4x
Tue, 21 Nov 2023US$1.6tUS$375.1bUS$33.9b25.8x48.1x4.4x
Thu, 19 Oct 2023US$1.7tUS$382.7bUS$44.7b17.6x37.5x4.4x
Sat, 16 Sep 2023US$1.8tUS$381.8bUS$43.9b18x39.9x4.6x
Mon, 14 Aug 2023US$1.8tUS$381.5bUS$43.9b18.7x40.2x4.6x
Wed, 12 Jul 2023US$1.7tUS$392.8bUS$60.2b18.4x27.5x4.2x
Fri, 09 Jun 2023US$1.7tUS$393.0bUS$60.5b18.8x28.5x4.4x
Sun, 07 May 2023US$1.7tUS$393.0bUS$59.5b19.4x28.9x4.4x
Tue, 04 Apr 2023US$1.6tUS$401.2bUS$69.4b15.9x23.1x4x
Thu, 02 Mar 2023US$1.5tUS$401.2bUS$69.8b18.2x22.2x3.9x
Sat, 28 Jan 2023US$1.7tUS$402.6bUS$69.4b17.7x24x4.1x
Mon, 26 Dec 2022US$1.8tUS$403.7bUS$70.7b16.8x24.8x4.4x
Wed, 23 Nov 2022US$1.7tUS$403.7bUS$70.7b15.6x24.6x4.3x
Fri, 21 Oct 2022US$1.6tUS$403.4bUS$72.1b13.1x21.9x3.9x
Sun, 18 Sep 2022US$1.6tUS$403.0bUS$71.3b13.8x22.3x3.9x
Tue, 16 Aug 2022US$1.7tUS$403.0bUS$70.3b15.3x23.5x4.1x
Thu, 14 Jul 2022US$1.7tUS$392.4bUS$65.1b21.5x25.7x4.3x
Sat, 11 Jun 2022US$1.6tUS$392.5bUS$64.8b20.7x24.9x4.1x
Mon, 09 May 2022US$1.6tUS$392.7bUS$62.9b20.5x25.9x4.1x
Wed, 06 Apr 2022US$1.7tUS$373.8bUS$60.3b21.2x27.4x4.4x
Fri, 04 Mar 2022US$1.6tUS$373.5bUS$60.3b20.6x25.7x4.2x
Sun, 30 Jan 2022US$1.6tUS$363.7bUS$40.7b21.9x39.1x4.4x
Tue, 28 Dec 2021US$1.7tUS$361.1bUS$37.9b22.9x44.1x4.6x
Price to Earnings Ratio

44.1x


Total Market Cap: US$1.7tTotal Earnings: US$37.9bTotal Revenue: US$361.1bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Pharma Industry Price to Earnings3Y Average 49.8x202220232024
Current Industry PE
  • Investors are optimistic on the American Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 57.1x which is higher than its 3-year average PE of 49.8x.
  • The industry is trading close to its 3-year average PS ratio of 4.6x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 6.4% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market-2.39%
Healthcare-2.38%
Pharma-1.58%
Pharma-1.58%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TEVA Teva Pharmaceutical IndustriesUS$22.0933.9%
+US$6.3b		110.8%PS1.5x
PFE PfizerUS$26.363.0%
+US$4.4b		-7.2%PE35x
BMY Bristol-Myers SquibbUS$57.332.8%
+US$3.1b		9.6%PS2.5x
EWTX Edgewise TherapeuticsUS$30.7811.4%
+US$299.2m		229.9%PB6x
OMER OmerosUS$10.3135.1%
+US$155.3m		184.0%PE-3.2x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BMY

US$57.33

Bristol-Myers Squibb

7D

2.8%

1Y

9.6%

Bristol-Myers Squibb Will Handle The Patent Cliff And Is Still Undervalued

Dec 20

MRK

US$98.05

Merck

7D

-3.9%

1Y

-9.0%

Merck (NYSE:MRK) Has A Pretty Healthy Balance Sheet

Dec 20
Merck (NYSE:MRK) Has A Pretty Healthy Balance Sheet

PFE

US$26.36

Pfizer

7D

3.0%

1Y

-7.2%

JNJ

US$144.47

Johnson & Johnson

7D

-1.5%

1Y

-7.1%

Johnson & Johnson: Dividend Legend At A Discount

Dec 19

LLY

US$767.76

Eli Lilly

7D

-2.7%

1Y

34.6%

GPCR

US$27.90

Structure Therapeutics

7D

-10.7%

1Y

-21.6%

EWTX

US$30.78

Edgewise Therapeutics

7D

11.4%

1Y

229.9%

CORT

US$51.40

Corcept Therapeutics

7D

-7.2%

1Y

56.9%

ZTS

US$164.84

Zoetis

7D

-7.5%

1Y

-15.5%

ELAN

US$11.63

Elanco Animal Health

7D

-3.9%

1Y

-20.7%

Elanco Animal Health Incorporated's (NYSE:ELAN) Business And Shares Still Trailing The Industry

Dec 12
Elanco Animal Health Incorporated's (NYSE:ELAN) Business And Shares Still Trailing The Industry

PRGO

US$25.75

Perrigo

7D

-6.2%

1Y

-18.8%

OMER

US$10.31

Omeros

7D

35.1%

1Y

184.0%

TEVA

US$22.09

Teva Pharmaceutical Industries

7D

33.9%

1Y

110.8%

Teva: Becoming Increasingly Solid, But No Longer Undervalued

Dec 04

NMRA

US$10.85

Neumora Therapeutics

7D

5.1%

1Y

-38.0%

HRMY

US$34.28

Harmony Biosciences Holdings

7D

5.8%

1Y

6.7%

Harmony Biosciences: sNDA Of WAKIX Brings Additional Value Inflection Points

Nov 11

SEPN

US$24.28

Septerna

7D

8.4%

1Y

n/a